- Home
- BAX vs FWONA Comparison
BAX vs FWONA Comparison
Compare BAX & FWONA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BAX
- FWONA
- Stock Information
- Founded
- BAX 1931
- FWONA 1950
- Country
- BAX United States
- FWONA United States
- Employees
- BAX N/A
- FWONA N/A
- Industry
- BAX Medical/Dental Instruments
- FWONA Broadcasting
- Sector
- BAX Health Care
- FWONA Industrials
- Exchange
- BAX Nasdaq
- FWONA Nasdaq
- Market Cap
- BAX 17.3B
- FWONA 19.1B
- IPO Year
- BAX N/A
- FWONA N/A
- Fundamental
- Price
- BAX $31.92
- FWONA $74.33
- Analyst Decision
- BAX Hold
- FWONA Buy
- Analyst Count
- BAX 10
- FWONA 2
- Target Price
- BAX $41.40
- FWONA $77.00
- AVG Volume (30 Days)
- BAX 3.6M
- FWONA 96.9K
- Earning Date
- BAX 11-08-2024
- FWONA 11-07-2024
- Dividend Yield
- BAX 3.63%
- FWONA N/A
- EPS Growth
- BAX N/A
- FWONA N/A
- EPS
- BAX 0.21
- FWONA 1.15
- Revenue
- BAX $15,062,000,000.00
- FWONA $3,716,000,000.00
- Revenue This Year
- BAX $3.81
- FWONA $20.76
- Revenue Next Year
- BAX $3.45
- FWONA $9.30
- P/E Ratio
- BAX $134.25
- FWONA $72.30
- Revenue Growth
- BAX 32.37
- FWONA 35.07
- 52 Week Low
- BAX $31.60
- FWONA $55.25
- 52 Week High
- BAX $44.01
- FWONA $79.67
- Technical
- Relative Strength Index (RSI)
- BAX 19.35
- FWONA 49.84
- Support Level
- BAX $31.61
- FWONA $74.09
- Resistance Level
- BAX $36.82
- FWONA $79.33
- Average True Range (ATR)
- BAX 0.82
- FWONA 2.15
- MACD
- BAX -0.41
- FWONA 0.00
- Stochastic Oscillator
- BAX 3.17
- FWONA 14.15
About BAX Baxter International Inc.
Baxter offers a variety of medical instruments and supplies to caregivers. It enhanced its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment, including hospital beds, to the portfolio, although about half of Hillrom's revenue comes from more digitally connected offerings like its smart beds and Voalte medical communications app. From its legacy operations, Baxter sells a variety of injectable therapies for use in care settings, such as IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. It has signed an agreement to sell its kidney care segment by early 2025.
About FWONA Liberty Media Corporation Series A Liberty Formula One
Formula One Group controls the exclusive commercial and promotional rights to the FIA Formula One World Championship series, and the monetization of those rights is the primary business of the group. The firm is responsible for development and promotion of the Formula One race series in concert with its three partners: the FIA (the regulatory body), the teams that participate in the series, and the series' commercial partners, which include the race promoters, broadcasters, sponsors, and advertisers. The F1 schedule in 2023 will encompass 23 races held on five continents. Formula One Group is a subsidiary of Liberty Media, which purchased the firm in January 2017. Formula One stock is a tracking stock for the assets under Formula One Group with Liberty Media.